Trial intelligence / Profile preview

Acetaminophen ER vs Ibuprofen for Ankle Sprains

NCT00261560Phase 4Completed

Sponsor
Johnson & Johnson
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of acetaminophen in Ankle sprain (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Change from baseline (Day 1) to Day 4 in the subject's pain upon walking. Status: completed.

02

Drugs

acetaminophen
03

Conditions

Ankle sprain

Beyond the preview

Go deeper on NCT00261560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00261560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call